Announcements Trials
Browse Landscape

Phase

Phase 2 51Phase 1 25Phase 1/2 8Phase 3 6Phase NA 4Phase 2/3 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Esophageal Squamous Cell Carcinoma 6Leukemia 5Esophageal Neoplasms 5Rectal Neoplasms 3Lymphoma 3Head and Neck Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Squamous Cell Carcinoma of Head and Neck 2Sarcoma 2Prostatic Neoplasms 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Oropharyngeal Neoplasms 2Oligodendroglioma 2Nasopharyngeal Carcinoma 2Myelodysplastic Syndromes 2Lung Neoplasms 2Leukemia, T-Cell 2Leukemia, Myeloid, Chronic-Phase 2Leukemia, Myeloid, Acute 2Leukemia, Myeloid, Accelerated Phase 2Carcinoma 2Astrocytoma 2Anemia, Refractory, with Excess of Blasts 2Adenocarcinoma Of Esophagus 2Uterine Cervical Neoplasms 1Stomach Neoplasms 1Sezary Syndrome 1Sarcoma, Synovial 1Sarcoma, Ewing 1

Interventions

Gemcitabine 16Fluorouracil 6Irinotecan 4Cisplatin 4Capecitabine 4Oxaliplatin 3Albumin-Bound Paclitaxel 3130-nm albumin-bound paclitaxel 3nimotuzumab 2Taxes 2Phytotherapy 2Leucovorin 2Drug Therapy 2surufatinib 1rubitecan 1racemetyrosine 1pertuzumab 1pembrolizumab 1methylnaltrexone 1folfirinox 1cyclopropapyrroloindole 1camrelizumab 1Trastuzumab 1Tranexamic Acid 1Standard of Care 1Sirolimus 1Radiotherapy 1Positron Emission Tomography Computed Tomography 1Phenytoin 1Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2/3 × Pancreatic Neoplasms × Radiotherapy × Clear all
NCT00064207 2012-09-24

Gemcitabine and Radiation Therapy Compared With Gemcitabine Alone in Treating Patients Who Have Undergone Surgery for Pancreatic Cancer

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2/3 Completed
97 enrolled
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡